drugset
Drugs / SHR-1826
last change 4 days ago re-read 2 minutes ago

SHR-1826

Developed for
non-small cell lung carcinoma · cancer · hepatocellular carcinoma · lung cancer
Investigated by
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Jiangsu Hansoh Pharmaceutical Co., Ltd. · Shandong Suncadia Medicine Co., Ltd. · Shanghai Zhongshan Hospital

Trials 9 · a red edge is where a trial was stopped

today NCT07704645 · Ph 2 NCT07489716 · Ph 2 NCT07414953 · Ph 1 NCT06935175 · Ph 2 NCT06915142 · Ph 2 NCT06844474 · Ph 2 NCT06754930 · Ph 1/2 NCT06703177 · Ph 1/2 NCT06094556 · Ph 1
20242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT07414953 Mar 2026 → Apr 2027 expected lung cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting No outcome recorded
Phase 1 NCT06094556 Dec 2023 → Jun 2027 expected cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT06754930 Feb 2025 → Dec 2027 expected non-small cell lung carcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting No outcome recorded
Phase 1/2 NCT06703177 Feb 2025 → Jan 2026 overdue cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting No outcome recorded
Phase 25 trials
Phase 2 NCT07704645 Aug 2026 → Jun 2028 expected non-small cell lung carcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. Not yet recruiting No outcome recorded
Phase 2 NCT07489716 Apr 2026 → Aug 2028 expected non-small cell lung carcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting No outcome recorded
Phase 2 NCT06935175 May 2025 → May 2027 expected hepatocellular carcinoma Shanghai Zhongshan Hospital Not yet recruiting No outcome recorded
Phase 2 NCT06915142 Apr 2025 → Dec 2026 expected cancer Shandong Suncadia Medicine Co., Ltd. Recruiting No outcome recorded
Phase 2 NCT06844474 Mar 2025 → Aug 2026 overdue non-small cell lung carcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as SHR-1826 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07704645 ↗
8

NCT06094556 ↗

NCT06703177 ↗

NCT06754930 ↗

NCT07489716 ↗

NCT07414953 ↗

NCT06935175 ↗

NCT06844474 ↗

NCT06915142 ↗
Route Intravenous “Administration by intravenous infusion” NCT06844474 ↗